Double-Blind Comparison of Hepatitis C Histological Recurrence Rate in HCV+ Liver Transplant Recipients Given Basiliximab+Steroids or Basiliximab+Placebo, in addition to Cyclosporine and Azathioprine-Reference-Cited by-同舟云学术

Double-Blind Comparison of Hepatitis C Histological Recurrence Rate in HCV+ Liver Transplant Recipients Given Basiliximab+Steroids or Basiliximab+Placebo, in addition to Cyclosporine and Azathioprine

Published:2004-11-27 Issue:10 Volume:78 Page:1488-1495
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Filipponi Franco,Callea Francesco,Salizzoni Mauro,Grazi Gian Luca,Fassati Luigi Rainero,Rossi Massimo,Risaliti Andrea,Burra Patrizia,Agnes Salvatore,De Carlis Luciano,Valente Umberto,Ferrara Roberto,Pisati Roberto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. Management of recurrent hepatitis C after liver transplantation.;Teixeira;J Viral Hepatitis,2001

2. Treatment for recurrent viral hepatitis after liver transplantation.;Brumage;J Hepatol,1997

3. Recurrent and acquired hepatitis C viral infection in liver transplant recipients.;Wright;Gastroenterology,1992

4. Association of Multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation.;Rosen;Gastroenterology,1999

5. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation.;Tisone;Transplantation,1999

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression and Liver Transplantation;Engineering;2023-02

2. Immunosuppression;Peri-operative Anesthetic Management in Liver Transplantation;2023

3. Immunosuppression in liver and intestinal transplantation;Best Practice & Research Clinical Gastroenterology;2021-10

4. Current management & future directions in post-liver transplant recurrence of viral hepatitis;Journal of Liver Transplantation;2021-07

5. Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT);HPB;2021-05